The SIRPAC study, presented at EuroPCR 2020 as late-breaking clinical trial, was accepted for publication in Cardiovascular Revascularization Medicine. Stay tuned!
Watch this video to discover the latest advancements on DCB.
My speech at min. 20 (in Italian).
Watch this video to discover something about DCB in de novo lesion
Speaker: Bernardo Cortese
Watch this roundtable discussion if you want:
- To learn and understand how and where to use a Sirolimus DCB in current practice
- To see clinical evidence and results for the treatment of patients with Sirolimus DCB
- To see the potential advantages of using the Sirolimus over Paclitaxel
Speakers: Antonio Colombo, Bernardo Cortese, Sandeep Basavarajaiah
EASTBOURNE registry finished the enrollment a few days ago, with the terrific number of 2100 patients reached: this is the largest coronary DCB study ever done.
EASTBOURNE is a prospective registry and will describe the immediate and long term performance of the novel Magic Touch sirolimus-coated balloon for any coronary application. Interesting, this is an investigator-driven study without bias or inferences from the industry.
I want to congratulate each investigator of the study and Prof Antonio Colombo, co-chairman of the study.
Top enrollers are: L. Testa, T. Heang, A. Ielasi, I. Bossi, R. Latini, L. Yan, I. Sanchez, D. Milazzo, G. Caiazzo, F. Tomai, G. Di Palma, S. Benincasa, M. Montorfano, A. Nuruddin, G. Stefanini, G. Seresini, R. Singh, G. Cacucci.
You can find the interim analysis publication (600 pts @1y.) here: https://pubmed.ncbi.nlm.nih.gov/32740442/
Bernardo Cortese, MD FESC